Assignee
AKAMARA THERAPEUTICS INC
US·8 granted patents·4 pending applications·2 citations·filing 2014–2024
Top patents by PatentIndex Score
12 records- 0179US10533059B2Targeted drug delivery through affinity based linkersAKAMARA THERAPEUTICS INC·Filed 2015·Granted Jan 14, 2020·2 cites·9 claims
- 0265US2024342128A1Immune memory induction by platinum based compoundsAKAMARA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0363US10730899B2Lipid-based platinum compounds and nanoparticlesAKAMARA THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·0 cites·27 claims
- 0460US12357699B2B-cell immunotherapy in cancer treatmentAKAMARA THERAPEUTICS INC·Filed 2019·Granted Jul 15, 2025·0 cites·14 claims
- 0558US11701429B2Targeted drug delivery through affinity based linkersAKAMARA THERAPEUTICS INC·Filed 2020·Granted Jul 18, 2023·0 cites·4 claims
- 0657US2020354394A1Lipid-based platinum compounds and nanoparticlesAKAMARA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0752US10081648B2Lipid-based platinum compounds and nanoparticlesAKAMARA THERAPEUTICS INC·Filed 2014·Granted Sep 25, 2018·0 cites·12 claims
- 0848US10800801B2Crystalline platinum-based compoundsAKAMARA THERAPEUTICS INC·Filed 2017·Granted Oct 13, 2020·0 cites·23 claims
- 0945US2022168261A1Compounds and methods for managing cancer through immune systemAKAMARA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1043US2019209513A1Immune memory induction by platinum based compoundsAKAMARA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1133US11554175B2Evaluation and optimization of supramolecular therapeuticsAKAMARA THERAPEUTICS INC·Filed 2017·Granted Jan 17, 2023·0 cites·2 claims
- 1233US11358978B2Process for preparing supramolecular platinum-based compoundsAKAMARA THERAPEUTICS INC·Filed 2016·Granted Jun 14, 2022·0 cites·23 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →